Biotinylated Recombinant SARS-CoV-2 S Protein S1 (carrier-free)

Pricing & Availability
Regulatory Status
RUO
Other Names
S1, Spike Protein
Ave. Rating
Submit a Review
Product Citations
publications
SARS-CoV-2_S_Protein_S1_CF_Biotin-RECOM_1_081920
When recombinant ACE2-Fc chimera (Cat. No. 793202) is immobilized at 1 µg/mL, biotinylated recombinant SARS-CoV-2 S Protein S1 binds in a dose-dependent manner. The EC50 range for this effect is 20 - 100 ng/mL. HRP Avidin (Cat. No. 405103) was used to detect the binding.
  • SARS-CoV-2_S_Protein_S1_CF_Biotin-RECOM_1_081920
    When recombinant ACE2-Fc chimera (Cat. No. 793202) is immobilized at 1 µg/mL, biotinylated recombinant SARS-CoV-2 S Protein S1 binds in a dose-dependent manner. The EC50 range for this effect is 20 - 100 ng/mL. HRP Avidin (Cat. No. 405103) was used to detect the binding.
  • SARS-CoV-2_S_Protein_S1_CF_Biotin-RECOM_2_081920
    Stability Testing for Biotinylated Recombinant SARS-CoV-2 S Protein S1. Biotinylated recombinant SARS-CoV-2 S Protein S1 was aliquoted in PBS, 5% glycerol at 0.2 mg/mL. One aliquot was frozen and thawed four times (4x Freeze/Thaw), and compared to a control kept at 4°C (Control). The samples were tested in a binding assay with recombinant human ACE2-Fc chimera (Cat. No. 793202).
Cat # Size Price Quantity Check Availability Save
793804 25 µg 329€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
793806 100 µg 728€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

SARS-CoV-2 is a respiratory virus which causes coronavirus disease 2019 (COVID-19). The coronavirus spike (S) glycoprotein is a class I viral fusion protein on the outer envelope of the virion that plays a critical role in viral infection by recognizing host cell receptors and mediating fusion of the viral and cellular membranes. The S glycoprotein is synthesized as a precursor protein consisting of ~1,300 amino acids that is then cleaved into an amino (N)-terminal S1 subunit (~700 amino acids) and a carboxyl (C)-terminal S2 subunit (~600 amino acids). Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. Triggered by receptor binding, proteolytic processing and/or acidic pH in the cellular compartments, the class I viral fusion protein undergoes a transition from a metastable pre-fusion state to a stable post-fusion state during infection, in which the receptor-binding subunit is cleaved, and the fusion subunit undergoes large-scale conformational rearrangements to expose the hydrophobic fusion peptide, induce the formation of a six-helix bundle, and bring the viral and cellular membranes close for fusion. The trimeric SARS coronavirus (SARS-CoV-2) S glycoprotein consisting of three S1-S2 heterodimers binds the cellular receptor angiotensin-converting enzyme 2 (ACE2) and mediates fusion of the viral and cellular membranes through a pre- to post-fusion conformation transition.

Product Details
Technical Data Sheet (pdf)

Product Details

Source
SARS-CoV-2 S Protein S1, amino acid Val16-Arg685 (Accession # QHD43416.1), with a C-terminal 8-his tag and an Avi-tag was expressed in CHO cells. SARS-CoV-2 S Protein S1 was site-specifically biotinylated by enzyme BirA.
Molecular Mass
The 707 amino acid recombinant protein has a predicted molecular mass of approximately 78.9 kD. The DTT-reduced and non-reduced proteins migrate at approximately 120 kD by SDS-PAGE. The predicted N-terminal amino acid is Val.
Purity
> 95%, as determined by Coomassie stained SDS-PAGE
Formulation
0.22 µm filtered protein solution is in PBS, pH 7.2
Endotoxin Level
Less than 0.1 EU per µg protein as determined by the LAL method
Concentration
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
When recombinant ACE2-Fc Chimera (Cat. No. 793202) is immobilized at 1 μg/mL, biotinylated recombinant SARS-CoV-2 S Protein S1 binds in a dose-dependent manner. The EC50 range for this effect is 20 - 100 ng/mL. HRP Avidin (Cat. No. 405103) was used to detect the binding.
Application

Bioassay

Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.

Product Citations
  1. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  2. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed

Antigen Details

Structure
Biotinylated
Distribution

SARS-CoV-2

Function
Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection
Interaction
Lung cells
Ligand/Receptor
ACE2
Bioactivity
Measured by its ability to bind recombinant human ACE2
Biology Area
COVID-19
Antigen References
  1. Lu R, et al. 2020. Lancet. 395:565-574.
  2. Li F. 2016. Annu Rev Virol. 3:237-261.
  3. Belouzard S, et al. 2012. Viruses. 4:1011-33.
  4. Song W, et al. 2018. PLoS Pathog. 14:e1007236.
  5. Shang J, et al. 2020. Nature. 581:221-224.
Gene ID
NA
UniProt
View information about S1 on UniProt.org
Go To Top Version: 1    Revision Date: 08.19.2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account